/
/
/

Blue Jet Healthcare Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
-14%10%-8%
-12%16%-19%
----18%
30%28%24%20%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
LUPIN
MANKIND
DRREDDY
AUROPHARMA
BLUEJET
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,899₹456833 Cr37.7712.0762.82₹11479 Cr
9,100₹245426 Cr83.9134.04128.41₹2568 Cr
4,857₹187320 Cr85.8916.7297.06₹2163 Cr
1,120₹113217 Cr25.099.4262.53₹5040 Cr
1,385₹112212 Cr33.299.7757.87₹3879 Cr
1,840₹101155 Cr92.526.829.25₹889 Cr
2,110₹97626 Cr17.6630.95154.36₹5333 Cr
2,327.9₹96859 Cr47.4213.7571.08₹1913 Cr
1,151₹96406 Cr29.925.3263.99₹4196 Cr
1,653.1₹93614 Cr25.2217.9596.84₹3505 Cr
571.15₹10962 Cr46.664.5113.73₹248 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022
₹293 Cr₹235 Cr₹192 Cr₹165 Cr₹355 Cr₹340 Cr₹318 Cr₹208 Cr₹163 Cr₹184 Cr₹167 Cr₹181 Cr₹180 Cr₹217 Cr₹169 Cr₹190 Cr
₹15 Cr₹23 Cr₹13 Cr₹24 Cr₹8 Cr₹12 Cr₹13 Cr₹12 Cr₹9 Cr₹9 Cr₹7 Cr₹8 Cr₹5 Cr₹6 Cr₹6 Cr₹7 Cr
₹308 Cr₹258 Cr₹206 Cr₹190 Cr₹363 Cr₹353 Cr₹332 Cr₹220 Cr₹172 Cr₹193 Cr₹174 Cr₹190 Cr₹185 Cr₹224 Cr₹175 Cr₹197 Cr
₹202 Cr₹170 Cr₹152 Cr₹116 Cr₹239 Cr₹205 Cr₹199 Cr₹143 Cr₹122 Cr₹139 Cr₹120 Cr₹125 Cr₹127 Cr₹153 Cr₹124 Cr₹138 Cr
₹113 Cr₹94 Cr₹60 Cr₹79 Cr₹129 Cr₹152 Cr₹137 Cr₹82 Cr₹53 Cr₹62 Cr₹61 Cr₹71 Cr₹64 Cr₹77 Cr₹58 Cr₹66 Cr
₹66 L₹58 L₹34 L₹5 Cr₹69 L₹3 L₹2 L₹2 L₹3 L₹3 L₹4 L₹4 L₹5 L₹33 L₹35 L₹35 L
₹106 Cr₹87 Cr₹54 Cr₹69 Cr₹123 Cr₹147 Cr₹132 Cr₹77 Cr₹49 Cr₹54 Cr₹44 Cr₹64 Cr₹58 Cr₹70 Cr₹51 Cr₹59 Cr
₹78 Cr₹64 Cr₹40 Cr₹52 Cr₹91 Cr₹110 Cr₹99 Cr₹58 Cr₹38 Cr₹40 Cr₹32 Cr₹48 Cr₹44 Cr₹51 Cr₹38 Cr₹44 Cr

Balance Sheet

Consolidated
Standalone
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
₹35 Cr₹35 Cr₹35 Cr₹35 Cr₹35 Cr₹10 Cr
₹1325 Cr₹1098 Cr₹811 Cr₹647 Cr₹487 Cr₹330 Cr
₹1325 Cr₹1098 Cr₹811 Cr₹647 Cr₹487 Cr₹330 Cr
₹1360 Cr₹1133 Cr₹845 Cr₹681 Cr₹522 Cr₹340 Cr
₹0₹0₹0₹0₹0₹29 Cr
₹11 Cr₹7 Cr₹3 Cr₹1 Cr₹26 L₹1 Cr
₹38 Cr₹17 Cr₹38 L₹2 Cr₹13 Cr₹1 L
₹302 Cr₹5 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr
₹350 Cr₹29 Cr₹8 Cr₹7 Cr₹17 Cr₹33 Cr
₹57 Cr₹89 Cr₹30 Cr₹54 Cr₹57 Cr₹60 Cr
₹56 Cr₹34 Cr₹51 Cr₹39 Cr₹32 Cr₹46 Cr
₹0₹0₹0₹0₹0₹7 Cr
₹164 Cr₹378 Cr₹281 Cr₹226 Cr₹170 Cr₹107 Cr
₹277 Cr₹501 Cr₹362 Cr₹318 Cr₹259 Cr₹220 Cr
₹1987 Cr₹1662 Cr₹1214 Cr₹1007 Cr₹798 Cr₹593 Cr
₹68 L₹68 L₹1 Cr₹12 Cr₹2 Cr₹2 Cr
₹0₹0₹0₹0₹0₹52 Cr
₹458 Cr₹421 Cr₹276 Cr₹231 Cr₹215 Cr₹176 Cr
₹141 Cr₹121 Cr₹104 Cr₹80 Cr₹58 Cr₹37 Cr
₹316 Cr₹300 Cr₹172 Cr₹151 Cr₹156 Cr₹139 Cr
₹301 Cr₹89 Cr₹147 Cr₹30 Cr₹3 Cr₹3 Cr
₹25 Cr₹0₹15 Cr₹0₹0₹0
₹25 Cr₹0₹15 Cr₹0₹0₹0
₹324 Cr₹22 Cr₹19 Cr₹15 Cr₹5 Cr₹5 Cr
₹14 Cr₹39 L₹24 L₹17 L₹10 L₹8 L
₹981 Cr₹412 Cr₹353 Cr₹197 Cr₹165 Cr₹146 Cr
₹227 Cr₹187 Cr₹235 Cr₹189 Cr₹94 Cr₹37 Cr
₹187 Cr₹264 Cr₹130 Cr₹126 Cr₹105 Cr₹118 Cr
₹339 Cr₹350 Cr₹177 Cr₹239 Cr₹227 Cr₹144 Cr
₹149 Cr₹120 Cr₹85 Cr₹66 Cr₹88 Cr₹70 Cr
₹18 Cr₹7 Cr₹15 Cr₹18 Cr₹8 Cr₹4 Cr
₹86 Cr₹324 Cr₹219 Cr₹172 Cr₹111 Cr₹74 Cr
₹1006 Cr₹1251 Cr₹861 Cr₹810 Cr₹633 Cr₹447 Cr
₹730 Cr₹750 Cr₹500 Cr₹491 Cr₹374 Cr₹227 Cr
₹1987 Cr₹1662 Cr₹1214 Cr₹1007 Cr₹798 Cr₹593 Cr
₹78₹65₹49₹39₹30₹3,428
₹78₹65₹49₹39₹30₹20

Cash Flow

Consolidated
Standalone
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
₹333 Cr₹406 Cr₹220 Cr₹217 Cr₹243 Cr₹190 Cr
₹1 Cr-₹8 Cr₹19 Cr₹18 Cr₹7 Cr₹17 Cr
₹109 Cr-₹263 Cr₹13 Cr-₹33 Cr-₹76 Cr-₹73 Cr
₹443 Cr₹135 Cr₹252 Cr₹202 Cr₹174 Cr₹135 Cr
₹334 Cr₹46 Cr₹241 Cr₹142 Cr₹146 Cr₹135 Cr
-₹276 Cr-₹35 Cr-₹264 Cr-₹147 Cr-₹76 Cr-₹56 Cr
-₹31 Cr-₹19 Cr-₹2 Cr-₹4 Cr-₹56 Cr-₹27 Cr
₹28 Cr-₹8 Cr-₹24 Cr-₹10 Cr₹14 Cr₹51 Cr
₹33 Cr₹41 Cr₹65 Cr₹75 Cr₹61 Cr₹10 Cr
₹61 Cr₹33 Cr₹41 Cr₹65 Cr₹75 Cr₹61 Cr

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)582.05
Volume (₹)4.42 L
High (₹)584.00
Upper Circuit694.80
Low (₹)565.50
Lower Circuit463.20
Prev Close579.00
52W High (₹)759.50
Price571.15
52W Low (₹)325.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)10961.90 Cr
Div. Yield (%)0.21
PE Ratio46.66
Debt to Equity0.00
Price to Book4.17
Book Value78.40
EPS (TTM)12.41
Face Value2.00
ROE (%)19.88

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
BLUEJETNSE
LTP
1W Low
1W High
Market cap (₹)
1899-21 (-1.09%)
1895
1984.80
4,56,833Cr
9100-139 (-1.50%)
9087
9467
2,45,426Cr
4857-193 (-3.82%)
4823
5066
1,87,320Cr
1120-71 (-5.96%)
1120
1187
1,13,217Cr
1385-38.5 (-2.70%)
1375.50
1426.10
1,12,212Cr
1840-98.5 (-5.08%)
1811.70
1949
1,01,155Cr
2110-61.5 (-2.83%)
2100.60
2192
97,626Cr
2327.9-55 (-2.31%)
2317
2419.20
96,859Cr
1151-27 (-2.29%)
1151
1179.90
96,406Cr
1653.1+7.8 (0.47%)
1622.60
1717
93,614Cr
571.15-6.5 (-1.13%)
565.50
599.90
10,962Cr

Blue Jet Healthcare Ltd Annual Results Key Takeaways

Basis: Consolidated annual results.

Blue Jet Healthcare Ltd Quaterly Results Key Takeaways